0.1TWD
8.46 MTWD
314.50 MTWD
About PHARMOSA BIOPHARM INC
Sector
Industry
CEO
Pei Kan
Website
Headquarters
Taipei
Founded
1990
ISIN
TW0006875008
FIGI
BBG015CHM0J1
Pharmosa Biopharm, Inc. engages in research and development, research, and sale of innovative drugs and medical equipment. Its products include metered dose inhalers, soft mist inhalers, and liquid nebulizers. The company was founded in 1990 and is headquartered in Taipei, Taiwan.
Trade directly on the supercharts through our supported, fully-verified and user-reviewed brokers.
Frequently Asked Questions
The current price of 6875 is 64.5 TWD — it has decreased by 1.23% in the past 24 hours.
Depending on the exchange, the stock ticker may vary. For instance, on TPEX exchange PHARMOSA BIOPHARM INC stocks are traded under the ticker 6875.
6875 stock is 4.04% volatile and has beta coefficient of 0.14. Check out the list of the most volatile stocks — is PHARMOSA BIOPHARM INC there?
Yes, you can track PHARMOSA BIOPHARM INC financials in yearly and quarterly reports right on TradingView.
6875 stock has fallen by 9.79% compared to the previous week, the month change is a 29.43% fall, over the last year PHARMOSA BIOPHARM INC has showed a 11.15% decrease.
6875 net income for the last quarter is −91.35 M TWD, while the quarter before that showed 230.65 M TWD of net income which accounts for −139.60% change. Track more PHARMOSA BIOPHARM INC financial stats to get the full picture.
No, 6875 doesn't pay any dividends to its shareholders. But don't worry, we've prepared a list of high-dividend stocks for you.
Like other stocks, 6875 shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade PHARMOSA BIOPHARM INC stock right from TradingView charts — choose your broker and connect to your account.
Investing in stocks requires a comprehensive research: you should carefully study all the available data, e.g. company's financials, related news, and its technical analysis. So PHARMOSA BIOPHARM INC technincal analysis shows the sell today, and its 1 week rating is strong sell. Since market conditions are prone to changes, it's worth looking a bit further into the future — according to the 1 month rating PHARMOSA BIOPHARM INC stock shows the strong sell signal. See more of PHARMOSA BIOPHARM INC technicals for a more comprehensive analysis.
If you're still not sure, try looking for inspiration in our curated watchlists.
If you're still not sure, try looking for inspiration in our curated watchlists.
EBITDA measures a company's operating performance, its growth signifies an improvement in the efficiency of a company. PHARMOSA BIOPHARM INC EBITDA is 20.50 M TWD, and current EBITDA margin is 6.52%. See more stats in PHARMOSA BIOPHARM INC financial statements.